国产成人mv免费视频_无码精品毛片波多野吉衣_在线毛片äV网站免费观看_成人亚洲av电影_亚洲爆乳成av人在线网站_中国熟妇乱子hdsex粗_国产无遮挡污在线观看免费Aⅴ_日韩经典精品无码一区18_欧美巨大另类极品ⅴideosbest_午夜成人免费看在线观看
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(華堂寧?)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(華堂寧?)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Announcements and Circulars
Search
Dec 21, 2023
VOLUNTARY ANNOUNCEMENT-IND APPLICATION OF 2nd GENERATION GLUCOKINASE ALLOSTERIC ACTIVATOR FILED WITH AND ACCEPTED BY FDA
Read More
Dec 13, 2023
VOLUNTARY ANNOUNCEMENT - INNOVATIVE FIRST-IN-CLASS GKA, HUATANGNING (華堂寧?) INCLUDED IN THE 2023 NATIONAL REIMBURSEMENT DRUG LIST
Read More
Dec 06, 2023
Monthly Return
Read More
Nov 22, 2023
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON RECEIPT OF THE MILESTONE PAYMENT UNDER THE COMMERCIALIZATION AGREEMENT IN RELATION TO HUATANGNING
Read More
Nov 06, 2023
Monthly Return
Read More
Oct 12, 2023
List of Directors and their Role and Function
Read More
Oct 12, 2023
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF REMUNERATION COMMITTEE
Read More
Oct 06, 2023
Monthly Return
Read More
Sep 06, 2023
Monthly Return
Read More
Aug 24, 2023
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Read More
Aug 18, 2023
BUSINESS UPDATE IN RELATION TO THE COMMERCIALIZATION OF HUATANGNING
Read More
Aug 14, 2023
Date of Board Meeting
Read More
<<
<
1
2
3
4
5
6
7
8
9
10
11
>
>>
上一頁
下一頁
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(華堂寧?)
Subscribe Email
Focus Us
Copyright ? 2024 Hua Medicine (Shanghai) Co., Ltd. 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號(hào): (滬)-非經(jīng)營(yíng)-2022-0079
滬ICP備14036654號(hào)-1
滬公網(wǎng)安備 31011502013809號(hào)
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x